Beijing Anlong Biopharmaceutical Co., Ltd.
Beijing Anlong Biopharmaceutical Co., Ltd.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD | Wet Age-related Macular Degeneration (wAMD) | Active, not recruiting | Phase 1 / Phase 2 | 2025-03-19 | NCT06707753 | |
| Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD | Wet Age-related Macular Degeneration (wAMD) | Not yet recruiting | Phase 2 | 2025-02-21 | NCT06839339 | |
| Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD | Wet Age-related Macular Degeneration (wAMD) | Recruiting | Not stated | 2024-12-05 | NCT06718816 |